 Role nerve-sparing radical prostatectomy clinical stage prostate cancer role nerve-sparing radical prostatectomy patients clinical stage prostate cancer first patients series nerve-sparing technique total patients underwent bilateral underwent unilateral nerve-sparing prostatectomy neurovascular bundles patients months bilateral unilateral nerve-sparing prostatectomy potency strict clinicopathological criteria organ-confined tumor intracapsular tumor negative surgical margins undetectable postoperative prostate specific antigen levels complete tumor excision patients bilateral unilateral nerve-sparing prostatectomy patients neurovascular bundles pathological stage disease patients complete tumor excision strict criteria potent patients potency patients positive margins seminal vesicle invasion pathological stage undetectable postoperative prostate specific antigen levels addition patients seminal vesicle involvement negative surgical margins undetectable postoperative prostate specific antigen levels patients complete tumor excision over-all complete tumor excision rate patients preservation potency patients clinical stage tumor potency histological serological evidence incomplete tumor excision patients pathological stage disease margins positive regions neurovascular bundles Preoperative prostate specific antigen acid phosphatase levels findings transrectal ultrasonography patients extracapsular tumor extension Patients tumors bulky disease rectal examination incidence extracapsular extension positive margins majority potent patients clinical stage prostate cancer goals nerve-sparing radical prostatectomy ABSTRACT TRUNCATED AT WORDS